'Oncology market' presentation slideshows

Wales Cancer Conference November 24 th 2017

NHS and Industry Improving cancer outcomes: Challenging pre-conceptions and delivering shared goals Professor Andrew Hughes Chair Experimental Cancer Medicine, University of Manchester. Wales Cancer Conference November 24 th 2017. Overview.

359 views • 35 slides

Orthopaedic Oncology Market Growth and Forecast 2015-2025

Orthopedic oncology accounts for a small proportion in orthopedics. Orthopedic oncology is a condition that arises due to the formation of benign and malignant tumors in bones and connective soft tissues. It also includes the diagnosis and treatment of patients with metastatic carcinomato the skeleton. Bone and soft tissue tumors are quite rare and sometimes require reconstructive surgery. Soft tissue sarcomas are more common than bone sarcomas. For 2016, the American Cancer Society estimates about 3,300 new cases for cancer of the bones and joints and 12,310 new cases for soft tissue sarcomas.

184 views • 7 slides

Sterile Medical Packaging Market Expected To Continue Healthy Growth Till 2021

The Sterile Medical Packaging Market deals with the development of packaging of medical products. Medical packaging is an integral part of product manufacturing. Sterile medical packaging is the process of packaging of medical products which ensures products safety and effortless transportation of products.

97 views • 7 slides

Oncology in China

The Oncology Market in China is Expected to Witness a High Growth Rate Driven by Growing Cancer Prevalence and Better Drug Access

510 views • 6 slides

World Cancer Drugs & Treatments Market Trends & Growth 2023

173 views • 6 slides

Cancer Generics Market Analysis

Bharat Book introduces a report "Cancer Generics Market Analysis". According to our latest research report, the global cancer generics market is anticipated to grow at a compound annual rate of around 26% during 2011-2015 as many anti-cancer blockbuster drugs are on the verge of patent expiry, and governments are introducing biogenerics for controlling rapidly increasing healthcare costs.

260 views • 4 slides